ANKRD11 and triple-negative breast carcinoma: Yuan et al. showed that high levels of nuclear ANCO1 predicted more favorable outcomes, especially in the triple-negative breast cancer (TNBC) subtype, and that loss of ANCO1 expression drove early-stage TNBC cells to more malignant phenotypes.